Vitalicious   Report issue

For profit
Founded: New York NY United States (1998)
Status: Left NME R&D (2008)

Organization Overview

First Clinical Trial
1998
NCT00097669
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1998

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (3)

folic acid (1 trial)

hydroxocobalamin (cyanokit) (1 trial)

pyridoxine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3